Home › NCT04872179

International Registry of Patients With Alpha Thalassemia

International Prospective Registry of Patients With Alpha Thalassemia

Who can join

All ages · All sexes

Inclusion Criteria:

* diagnosis of alpha thalassemia (prenatal or postnatal) with genotype consistent with ATM or BHFS phenotype
* referred to the University of California, San Francisco Fetal Treatment Center for fetal diagnosis, management and/or evaluation for the ongoing in utero stem cell transplantation clinical trial

Exclusion Criteria:

\- none

About the study

This is an international prospective registry of patients with Alpha thalassemia to understand the natural history of the disease and the outcomes of fetal therapies, with the overall goal of improving the prenatal management of patients with Alpha thalassemia.

Sponsor: University of California, San Francisco · Participants: 500 · Started: 2017-01

Contact the study team

• Billie Lianoglou, LCGC · Phone: (415) 476-2461

Official record on ClinicalTrials.gov — NCT04872179

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.